Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f26e47814be93b0f76010d9e063bc464 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e09ba4bc60bc471c6600808b9b959d9f http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9a2e6f9483cbf992a6db4522084e735a http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_132fdcfe392ab7f6353c51f2f492b527 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1c8001a714a8ca9e2f42980311f5034d |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-12 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-00 |
filingDate |
2001-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18887fe5598fe8ccd2e5793b30ff8886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f48214361aaa967bdd735fa259c7f8f3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd9e88a84d946be180a93668ab9b7897 |
publicationDate |
2002-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-0245687-A2 |
titleOfInvention |
Topical alcoholic solution of a salicylic acid derivative and acemannan |
abstract |
The invention provides an alcoholic solution of a physiologically tolerable salicylic acid derivative and an acemannan for use in topical treatment of herpetic neuralgia. The invention also provides a method of treatment of herpetic neuralgia in a human subject which comprises applying an analgesically effective amount of such a solution to the affected area. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8357393-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8784878-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-3130556-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2266533-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1534235-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1534235-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1716855-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1716855-A4 |
priorityDate |
2000-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |